Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 309

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 10
Chunk 309
---
 his career at Drexel Burnham where he was an
Executive Vice President running the global equity division as well as being on the Executive Committee. Mr. Kirsch has served on the
Board of Kadmon since 2019, a publicly traded bio pharmaceutical company where he serves on the Audit Committee. He also serves on the
board of Liquidia Technologies a public nano technology healthcare company as well as being the Chairman of the Audit Committee. Mr.
Kirsch received his B.A. in Finance from the University of Rhode Island and an M.B.A. from Bernard M. Baruch College.

Mark
Dant. Mr. Dant, EveryLife Foundation for Rare Diseases Board Chair, is a parent advocate and retired Carrolton, Texas Police
Department Chief of Police. Mark and his wife Jeanne are the parents of Ryan, who is 33 years old and the longest treated person in the
world with MPS I. Mark and Jeanne spearheaded the funding for the first MPS Enzyme Replacement Therapy, Aldurazyme, through their Foundation,
the Ryan Foundation. In partnership with Dr. Emil Kakkis, Mr. Dant and his family were also key advocates speaking to the FDA about the
importance and significant impact of ERT for the treatment of mucopolysaccharidoses. In 2009, Mr. Dant and his family successfully championed
Congress to pass the Ryan Dant Health Care Opportunity Act, H.R. 1441-111.

99

Family
Relationships

There
are no family relationships among any of our directors or executive officers, except that Christer Rosén, our Chief Executive
Officer, is the father of Alexander Rosén, our Chief Administrative Officer.

Involvement
in Certain Legal Proceedings

No
executive officer, member of the board of directors or control person of our Company has been involved in any legal proceeding listed
in Item 401(f) of Regulation S-K in the past 10 years.

Board
Leadership Structure and Board’s Role in Risk Oversight

We
have not separated the positions of Chairman of the Board and Chief Executive Officer. Christer Rosén has served as our Chairman
of the Board of Directors and Chief Executive Officer since January 1, 2016. We believe that combining the positions of Chairman and
Chief Executive Officer allows for focused leadership of our organization which benefits us in our relationships with investors, customers,
suppliers, employees and other constituencies. We believe that consolidating the leadership